Skip to content

A prospective randomised double-blinded comparison of 0.125% and 0.0625% bupivicaine for the management of postoperative pain in patients undergoing major abdominal surgery.

-

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN45045119
Enrollment
86
Registered
2003-09-12
Start date
2002-05-31
Completion date
Unknown
Last updated
2020-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Signs and Symptoms: Post operative pain Surgery

Interventions

Randomised controlled trial and telephone interviews for patient centered phase

Sponsors

Department of Health (UK)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 86 patients undergoing major abdominal surgery nursed with epidural for postoperative pain relief, randomised to two groups

Exclusion criteria

Exclusion criteria: Does not meet inclusion criteria

Design outcomes

Primary

MeasureTime frame
Pain relief response to therapy

Secondary

MeasureTime frame
Not provided at time of registration

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026